Hazard
823 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 823 gmp violation recalls we have scored against our rubric, 49 (6%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 376 (46%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all gmp violation recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Well Care Compounding Pharmacy is recalling 1-HCG 2000 IU/ML vials due to GMP violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Phenylephrine 0.5% vials because FDA inspections found violations that may affect sterility.
Well Care Compounding Pharmacy is recalling Atropine Sulfate 0.5% Ophthalmic Drops due to FDA inspection findings of GMP violations that may impact sterility.
Well Care Compounding Pharmacy is recalling TRI-MIX # 6 vials because FDA inspections found violations that may affect product sterility.
Well Care Compounding Pharmacy is recalling 869 vials of Methylcobalamin 12.5mg/mL due to FDA inspection findings of GMP violations that may impact sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PGE1/PHENTO injection vials because an FDA inspection identified GMP violations that may impact product sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PGE1/PHENTO injection vials because an FDA inspection found GMP violations that may affect sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PGE 30mcg/ml Injection vials because an FDA inspection identified GMP violations that may impact sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PGE1/PHENTO Injection vials because an FDA inspection found GMP violations that may affect sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PHENTO Injection vials because an FDA inspection found GMP violations that may affect sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PGE 20mcg/ml Injection vials due to FDA inspection findings of GMP violations that may impact sterility.
B&B Pharmacy is recalling specific vials of PAPA/PGE1/PHENTO Injection because FDA inspections found GMP violations that may affect sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling Testosterone Cypionate 250 mg/mL Injection due to FDA inspection findings of GMP violations that may impact sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling Testosterone Propionate Injection due to FDA inspection findings of GMP violations that may impact sterility.
Pacific Healthcare is recalling Nandrolone 200 mg/ml Injection vials because an FDA inspection found GMP violations that may impact sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PGE 25mcg/ml Injection vials because an FDA inspection identified GMP violations that may impact sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PHENTO Injection vials because FDA inspections identified GMP violations that may affect sterility.
Pacific Healthcare, Inc. is recalling Stanozolol 200 mg/ml Injection vials due to FDA inspection findings of GMP violations that may impact sterility.
B&B Pharmacy is recalling PAPA+PGE1+PHENTO Injection vials because an FDA inspection found GMP violations that may affect sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PGE1/PHENTO Injection vials because an FDA inspection identified GMP violations that may impact sterility.
Pacific Healthcare, Inc dba B&B Pharmacy is recalling PAPA/PGE1/PHENTO Injection vials because an FDA inspection identified GMP violations that may impact product sterility.
The Compounding Pharmacy of America is recalling Estradiol 18 mg sterile pellets due to GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Sermorelin/GHRP2 Injection due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Tri-Mix AT-6 Injectable due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Estradiol 100 mg sterile pellets nationwide because FDA inspections found GMP violations that may impact sterility.